ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,346.99
-0.11%
Dow Jones
38,798.99
-0.22%
US Dollar vs MXN
18.4137
2.95%
Brent Oil
79.395
-0.61%
Bitcoin
69,360.77
-1.98%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Integra LifeSciences Holdings Corporation (IART)

  7. Integra LifeSciences Holdings Corporation (IART) Noticias

IART Integra LifeSciences Holdings Corporation

30.95
-0.16 (-0.51%)
Fuera de horario
Última actualización: 17:51:05
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Integra LifeSciences Holdings Corporation IART NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.16 -0.51% 30.95 17:51:05
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
30.83 30.76 31.35 30.80 31.11
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
07/6/202417:09PRNUSKKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500;..
30/5/202415:40EDGAR2Form SD - Specialized disclosure report
24/5/202415:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202415:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/5/202415:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/5/202415:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/5/202415:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/5/202415:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/5/202415:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/5/202415:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/5/202415:38EDGAR2Form 8-K - Current report
13/5/202415:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/5/202415:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/5/202415:30GLOBEIntegra LifeSciences to Present at the 2024 Bank of America..
06/5/202415:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/5/202405:15EDGAR2Form 8-K - Current report
06/5/202405:00GLOBEIntegra LifeSciences Reports First Quarter 2024 Financial..
30/4/202415:20GLOBEIntegra LifeSciences to Spotlight CereLink® Intracranial..
18/4/202416:24GLOBEIntegra LifeSciences to Reschedule the First Quarter 2024..
01/4/202415:15GLOBEIntegra LifeSciences Completes the Acquisition of Acclarent,..
11/3/202407:30GLOBEIntegra LifeSciences Launches MicroMatrix® Flex to Provide..
08/3/202415:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202416:53EDGAR2Form 144 - Report of proposed sale of securities
28/2/202405:15EDGAR2Form 8-K - Current report
28/2/202405:10EDGAR2Form 8-K - Current report
28/2/202405:00GLOBEIntegra LifeSciences Reports Fourth Quarter and Full-Year..
27/2/202416:15EDGAR2Form 8-K/A - Current report: [Amend]
22/2/202415:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202415:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202415:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202415:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202414:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202416:49EDGAR2Form SC 13G - Statement of acquisition of beneficial..
07/2/202408:15GLOBEIntegra LifeSciences to Host Fourth Quarter and Full Year..
19/1/202415:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202415:30GLOBEIntegra LifeSciences to Present at the 42nd Annual J.P...
20/12/202315:57EDGAR2Form 8-K - Current report
13/12/202315:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202315:43EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/12/202315:31EDGAR2Form 8-K - Current report
13/12/202306:03DJNIntegra LifeSciences to Buy Acclarent From Johnson & Johnson
13/12/202305:30EDGAR2Form 8-K - Current report
13/12/202305:15GLOBEIntegra LifeSciences Announces Definitive Agreement to..
12/12/202311:00GLOBEIntegra LifeSciences Appoints Jeff Graves, Ph.D., to Board..
07/11/202312:54PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
03/11/202315:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202321:50PRNUSFILING DEADLINE--Kuznicki Law PLLC Announces Class Action on..
31/10/202304:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
25/10/202315:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
25/10/202305:15EDGAR2Form 8-K - Current report

Su Consulta Reciente

NASDAQ
IART
Integra LifeSciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados